Labshake search
Citations for R&D Systems :
601 - 650 of 3455 citations for 7 Chloro 2 hydrazino 5 phenyl 3H 1 4 benzodiazepine since 2019
Citations are collected from bioRxiv only, the total number of publications could be much larger.
-
bioRxiv - Immunology 2022Quote: ... goat anti-ACE-2 (R&D systems, #AF933, 1;1000), rabbit anti-STING (Cell Signaling ...
-
bioRxiv - Immunology 2022Quote: Recombinant Human IL-2 was from R&D systems. Dual-Luciferase Report Assay System was purchased from Promega ...
-
bioRxiv - Neuroscience 2019Quote: ... 2 µM tetrodotoxin citrate (TTX, R&D Systems 1078) or 25 mM glutamate (Sigma G1251 ...
-
bioRxiv - Cancer Biology 2019Quote: ... and 20 ng/mL FGF-2 (R&D Systems) in a humidified incubator with 5% CO2 ...
-
bioRxiv - Cancer Biology 2020Quote: ... and IL-2 (100 U/ml; R&D Systems) at 37°C and 5% CO2 ...
-
bioRxiv - Cancer Biology 2019Quote: ... and 20 ng/mL FGF-2 (R&D Systems) in a humidified incubator with 5% CO2.
-
bioRxiv - Developmental Biology 2022Quote: ... and 2 ng/ml human BMP4 (R&D Systems). The plates were centrifugated at 210 g for 4 min to promote cell aggregation before incubation at 37 °C under 5% CO2 normoxic condition ...
-
bioRxiv - Pharmacology and Toxicology 2022Quote: ... dilution series of native relaxin-2 (R&D Systems), were added to the cells and luminescence measurements were taken 30 minutes after relaxin-2 addition ...
-
bioRxiv - Neuroscience 2023Quote: ... and 40 ng/ml FGF-2 (R&D Systems) on poly-lysine (Sigma ...
-
bioRxiv - Cell Biology 2023Quote: ... 2% Noggin/R-Spondin–conditioned media (R&D Systems), 100 ng/mL recombinant human Wnt3A (R&D Systems) ...
-
bioRxiv - Cancer Biology 2023Quote: ... mIL-2 (10 ng/ml; R&D Systems Inc) was added to the culture medium from day 1 to expand iTregs ...
-
bioRxiv - Developmental Biology 2023Quote: ... and IGF-2 (#292-G2-250, R&D systems). Additionally ...
-
bioRxiv - Cell Biology 2023Quote: ... or TGF-ϕ31 (2 ng/ml; R&D System). For viral transduction ...
-
bioRxiv - Cell Biology 2024Quote: ... and IGF-2 (#292-G2-250, R&D systems). Additionally ...
-
bioRxiv - Developmental Biology 2020Quote: ... mouse anti-Nkx2-5 (25 μg/ml, R&D Systems, #259416), rabbit anti-MYL7 (1:1000 ...
-
bioRxiv - Developmental Biology 2019Quote: ... 5 ng/mL human recombinant FGF2 (R&D Systems #3139-FB) and 10μM of XAV939 (Abcam #ab120897) ...
-
bioRxiv - Molecular Biology 2022Quote: ... mice were treated with 5 µg RSPO3 (R&D systems #4120RS025CF) in 100 µL PBS 18 ...
-
bioRxiv - Neuroscience 2020Quote: ... SCH 23390 hydrochloride (5 μM; R&D Systems, Minneapolis, MN, USA) was added to the aCSF ...
-
bioRxiv - Immunology 2021Quote: ... and recombinant human IL-1β (5 units/mL; R&D Systems) in the presence or absence of PAD2/PAD4 inhibitor (5 μM YW3-56 ...
-
bioRxiv - Neuroscience 2021Quote: ... 5 ng/mL HB-EGF (R&D Systems, 259-HE-050), 10 ng/mL CNTF (R&D Systems ...
-
bioRxiv - Cancer Biology 2020Quote: ... and 5 ng/ml recombinant human TGF-β (R&D Systems). After 72 h ...
-
bioRxiv - Genomics 2019Quote: ... and RUNX1 inhibitor (Ro 5-3335, R&D Systems, Shanghai, China) were added at 5 ng/mL and 10 ng/mL ...
-
bioRxiv - Microbiology 2020Quote: ... supplemented with 5% fetal bovine serum (FBS, R&D SYSTEMS, S11150) and 1% penicillin/streptomycin (P/S ...
-
bioRxiv - Immunology 2020Quote: ... and 5 μg of anti-ACE2 antibody (R&D systems, AF933) or isotope control IgG (R&D systems ...
-
bioRxiv - Neuroscience 2023Quote: ... 5 ng/mL HB-EGF (R&D Systems 259-HE-050), and 20 ng/mL FGF-2 (R&D Systems ...
-
bioRxiv - Neuroscience 2023Quote: ... Membranes were blocked in 5% nonfat skim milk (R&D Systems) for 1 h at room temperature ...
-
bioRxiv - Immunology 2023Quote: ... supplemented with 5 ng/ml BMP4 (R&D Systems, 314-BP), 50 ng/ml VEGF (R&D Systems ...
-
bioRxiv - Immunology 2023Quote: ... supplemented with 5% fetal bovine serum (R&D systems; cat# S11150), 0.4 μg/ml hydrocortisone (Sigma ...
-
bioRxiv - Biochemistry 2023Quote: ... (v) 5 µg/ml human DC-SIGN-Fc (R&D System), 5 µg/ml human MGL-Fc (R&D System ...
-
bioRxiv - Cell Biology 2024Quote: ... 5 ng/ml recombinant human VEGF 165 protein (R&D Systems), 10 ng/ml human bFGF (Invitrogen) ...
-
bioRxiv - Cell Biology 2024Quote: ... 5 ng/mL recombinant human VEGF 165 Protein (R&D Systems) and 0.25 ng/mL recombinant human BMP-4 Protein (R&D Systems).Cells were cultured for 28 hours ...
-
bioRxiv - Immunology 2020Quote: ... cells were pelleted and resuspended in 100 µL FACS buffer (2% FBS in DPBS) containing 0.2 µg goat-α-human Ace-2 (R&D Systems #AF933). After 30 min on ice ...
-
bioRxiv - Immunology 2020Quote: ... Cultures were supplemented 2 days later with 1.25 ml of R15 containing 100 U/ml recombinant human IL-2 (R&D systems; R15-100). R15-100 was added every 2 to 3 days thereafter ...
-
bioRxiv - Molecular Biology 2023Quote: Polystyrene microtiter plates were coated with 1 µg/ml recombinant SARS-CoV-2 spike protein produced in HEK293T cells (10549-CV-100, R&D Systems and Biotech, NE, MN, USA) while some plates were coated with 50 ng/ml SARS-CoV-2 S protein RBD or Biotinylated hACE2 (0.2 µg/ml ...
-
bioRxiv - Cell Biology 2020Quote: ... and BMP4-Lif (10 ng/mL of mouse BMP-4 R&D Systems,Inc. ...
-
bioRxiv - Genomics 2020Quote: ... 4 μg normal rabbit IgG (R&D Systems, AB-105-C, lot: ER1212071) and ChIP-grade protein G magnetic beads (Cell Signalling 9006S ...
-
bioRxiv - Immunology 2022Quote: ... 30 μg/mL LPS plus 25 ng/mL IL-4 (R&D Systems); or 5 μg/mL LPS ...
-
bioRxiv - Cell Biology 2022Quote: ... and human bone morphogenetic protein 4 (hBMP4, 1.5 ng/ml; R&D Systems) together with human vascular endothelial growth factor (hVEGF ...
-
bioRxiv - Neuroscience 2022Quote: ... 25 µg/ml human recombinant Bone Morphogenetic Protein 4 (BMP4, R&D Systems) and 55 µM β-mercaptoethanol (Life technologies) ...
-
bioRxiv - Cancer Biology 2020Quote: ... fibroblasts were treated for 4 days with recombinant human OSM (R&D Systems) at 10 ng/μl or vehicle (PBS ...
-
bioRxiv - Neuroscience 2020Quote: ... Antibodies used to assess pluripotency were anti-OCT3/4 (R&D Systems AF1759), anti-SOX2 (BD 245619) ...
-
bioRxiv - Immunology 2022Quote: ... or 4 μg/mL of anti-CCL1 Ab (clone 148113; R&D Systems), was added to the cultures.
-
bioRxiv - Immunology 2022Quote: ... 4 μg/mL of anti-CCL5 Ab (polyclonal goat IgG; R&D Systems), or 4 μg/mL of anti-CCL1 Ab (clone 148113 ...
-
bioRxiv - Developmental Biology 2023Quote: ... Cells were cultured for 4 days with 3 μM CHIR (R&D Systems); 3 days with 200 ng/mL FGF9 (R&D Systems) ...
-
bioRxiv - Immunology 2023Quote: ... and 10 ng/mL of IL-4 (R&D systems, 402-ML-020)) ...
-
bioRxiv - Immunology 2023Quote: ... with 50 ng/ml of IL-4 (R&D systems, Minneapolis, MN, USA) and 50 ng/ml of GM-CSF (R&D Systems ...
-
bioRxiv - Cancer Biology 2023Quote: ... and recombinant human TIM-4-HIS (R&D Systems, Cat# 9407-TM-050)) ...
-
bioRxiv - Bioengineering 2023Quote: ... at 4°C for 16 h and measured via ELISA (R&D Systems). The distribution of TGF-β in Ø2×2 mm and Ø5×2 mm constructs was predicted via FE model (FEBio ...
-
bioRxiv - Cell Biology 2024Quote: ... 15 ng/mL BMP-4 (314-BP-050/CF; R&D Systems Inc) and 125 ng/mL Fibroblast growth factor (FGF ...
-
bioRxiv - Cancer Biology 2022Quote: PBMC (2×106 per well) were stimulated in 24-well plates with peptide (individual/pool) plus recombinant IL-2 (R&D Systems Europe Ltd.) at a final concentration of 5μg/mL and 20IU/mL ...